4.5 Article

No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia

Journal

NEUROBIOLOGY OF AGING
Volume 28, Issue 11, Pages 1789-1790

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2006.07.016

Keywords

CHMP2B; POU1F1; frontotemporal dementia; genetic analysis; association study

Ask authors/readers for more resources

Mutations of the chromatin modifying protein 213 gene (CHMP2B) were identified, in a Danish pedigree, to cause familial frontotemporal dementia (FTD). To explore the possible genetic contribution of common CHMP2B variants in sporadic FFD, we analyzed 14 single nucleotide polymorphisms covering the entire genomic region of CHMP2B. After adjustment for multiple testing single marker and haplotype analysis revealed no significant association with sporadic FTD. Thus, we conclude that CHMP2B can be excluded as a susceptibility gene conferring risk to sporadic forms of FTD. (c) 2006 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available